The overall goals of this investigation are to determine the effects of substance P on HIV infection of human monocyte/macrophages and the mechanism of these effects. The hypothesis to be investigated is that tachykinins, in particular substance P, may play a central role in stressed HIV-1 infected patients and further trigger progression to AIDS and immune deficiency by affecting monocyte/macrophage functions. The immunopathogenesis of HIV-1 infection and diseases with psychoneuroimmunologic manifestations are likely to be modulated by substance P. We will determine the effects of Substance P on HIV- 1 infection in vitro of monocytes/macrophages from healthy donors. Our preliminary data indicate that substance P enhances infectivity of certain strains of HIV-1 for human monocytes/macrophages as determined by reverse transcriptase activity and p24 antigen expression and that substance P reverses LPS induced inhibition of HIV-1 RT expression in primary monocyte- derived macrophages. We will study interaction between monocyte/macrophage activators and substance P in HIV-1 infected cells. We will determine the mechanism of the effects of substance P on HIV-1 infection of primary monocytes/macrophages in vitro. We will determine whether primary monocytes/macrophages produce endogenous substance P and whether production can be affected by HIV-1 infection in vitro. We will study the role of substance P in facilitating HIV-1 fusion. We will study the effects of substance P on HIV-1 LTR promoter in monocytes/macrophages and a promonocytic cell line. We will also determine whether treatment of primary monocyte/macrophage cultures with substance P has a direct effect on HIV-1 binding to the cells. We will study the effect of substance P on monokine production and CD4 receptor expression in monocytes/macrophages. These studies will provide new insights into substance P regulation of monocyte/macrophage function and the effects of HIV-1 infection on the mononuclear phagocyte system. These findings have direct relevance to the in vivo immunopathogenesis of the psychologic, psychiatric and neurologic complications of HIV-1 infection and AIDS. An understanding of the influence of substance P on HIV-1 infection of monocyte/macrophages should lead to new approaches toward therapeutic intervention.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
1R01MH049981-01A3
Application #
2249353
Study Section
Psychobiological, Biological, and Neurosciences Subcommittee (MHAI)
Project Start
1995-07-01
Project End
1998-06-30
Budget Start
1995-07-01
Budget End
1996-06-30
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Children's Hospital of Philadelphia
Department
Type
DUNS #
073757627
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Douglas, Steven D (2016) Substance P and sickle cell disease-a marker for pain and novel therapeutic approaches. Br J Haematol 175:187-188
Barrett, Jeffrey S; Spitsin, Sergei; Moorthy, Ganesh et al. (2016) Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIV. J Transl Med 14:148
McGuire, Jennifer L; Gill, Alexander J; Douglas, Steven D et al. (2015) Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders. J Neurovirol 21:439-48
Tebas, Pablo; Spitsin, Sergei; Barrett, Jeffrey S et al. (2015) Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults. AIDS 29:931-9
McGuire, Jennifer L; Kempen, John H; Localio, Russell et al. (2015) Immune markers predictive of neuropsychiatric symptoms in HIV-infected youth. Clin Vaccine Immunol 22:27-36
McGuire, Jennifer L; Barrett, Jeffrey S; Vezina, Heather E et al. (2014) Adjuvant therapies for HIV-associated neurocognitive disorders. Ann Clin Transl Neurol 1:938-52
Tuluc, Florin; Meshki, John; Spitsin, Sergei et al. (2014) HIV infection of macrophages is enhanced in the presence of increased expression of CD163 induced by substance P. J Leukoc Biol 96:143-50
Schwartz, Lynnae; Spitsin, Sergei V; Meshki, John et al. (2013) Substance P enhances HIV-1 infection in human fetal brain cell cultures expressing full-length neurokinin-1 receptor. J Neurovirol 19:219-27
Spitsin, Sergei; Tuluc, Florin; Meshki, John et al. (2013) Analog of somatostatin vapreotide exhibits biological effects in vitro via interaction with neurokinin-1 receptor. Neuroimmunomodulation 20:247-55
Spitsin, Sergei; Stevens, Kathleen E; Douglas, Steven D (2013) Expression of substance P, neurokinin-1 receptor and immune markers in the brains of individuals with HIV-associated neuropathology. J Neurol Sci 334:18-23

Showing the most recent 10 out of 33 publications